Text Size

Osteoporosis Disease Management Demonstration Project

This study has been completed.
Sponsor:
Information provided by:
Merck
ClinicalTrials.gov Identifier:
NCT00139425
First received: August 29, 2005
Last updated: October 25, 2009
Last verified: October 2009
History of Changes
  Purpose

The purpose of this study is to assess the impact of disease management interventions on bone mineral density (BMD) screening rates and osteoporosis treatment rates in women age 65 years or older.


Condition Intervention
Osteoporosis
 Behavioral: Disease Management Assessment

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Osteoporosis Prevention and Treatment Program: A Disease Management Demonstration Project

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Merck:

Primary Outcome Measures:
  • Bone mineral density (BMD) testing rates

Secondary Outcome Measures:
  • Osteoporosis medication treatment rates

Estimated Enrollment: 10000
Study Start Date: May 2003
Primary Completion Date: December 2004 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   65 Years to 89 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Members of the Henry Ford Health System

Exclusion Criteria:

  • Individuals who are not members of the Henry Ford Health System
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00139425

Sponsors and Collaborators
Merck
Investigators
Study Director: Medical Monitor Merck
  More Information

No publications provided by Merck

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Executive Vice President, Clinical and Quantitative Sciences, Merck & Co., Inc.
ClinicalTrials.gov Identifier: NCT00139425     History of Changes
Other Study ID Numbers: 2005_048, 037
Study First Received: August 29, 2005
Last Updated: October 25, 2009
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on May 22, 2013